Shoubao Ma

6PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 06, 2026
Optimizing In Vivo CAR T-cell Engineering for Cancer Immunotherapy.

Ruiheng Wang, Jianhua Yu, Michael A Caligiuri

|Aug 18, 2025
Loss of YTHDF2 enhances Th9 programming and CAR-Th9 cell antitumor efficacy.

Sai Xiao, Songqi Duan, Yaqun Hong

|Apr 04, 2024
Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non-Small Cell Lung Cancer.

Ting Lu, Rui Ma, Anthony G Mansour

|Aug 02, 2023
Harnessing Natural Killer Cells for Lung Cancer Therapy.

Shoubao Ma, Michael A Caligiuri, Jianhua Yu

|Apr 14, 2022
Adipocyte CD1d Gene Transfer Induces T Cell Expansion and Adipocyte Inflammation in CD1d Knockout Mice.

Run Xiao, Anthony G Mansour, Wei Huang

|Jan 14, 2022
PDGF-D-PDGFRβ signaling enhances IL-15-mediated human natural killer cell survival.

Shoubao Ma, Tingting Tang, Xiaojin Wu

Pageof 1

Frequent Collaborators

6 joint publications

Michael A Caligiuri

6 joint publications

Jianhua Yu

2 joint publications

Anthony G Mansour

1 joint publications

Tingting Tang